Chemical Market Reports

Global Cancer Test Market By Type (Laboratory Tests, Genetic Tests, Imaging, and Endoscopy), By Application (Bladder Cancer Test, Breast Cancer Test, Cervical Cancer Test, Colorectal (Colon) Cancer Test, Ovarian Cancer Test, Prostate Cancer Test, Liver Cancer Test, Flow Cytometry, and Other Organ Specific Cancer Test), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 142802
  • 20-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Cancer Test Market is estimated to be valued US$ XX.X million in 2019. The report on Cancer Test Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global cancer test market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Cancer Test Market Scope:

    By type, the market is segmented into Laboratory Tests, Genetic Tests, Imaging, and Endoscopy. By Application, the market is divided into Bladder Cancer Test, Breast Cancer Test, Cervical Cancer Test, Colorectal (Colon) Cancer Test, Ovarian Cancer Test, Prostate Cancer Test, Liver Cancer Test, Flow Cytometry, and Other Organ Specific Cancer Test.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Abbott, Radient Pharmaceuticals, BD Diagnostics, Beckman Coulter, BioCurex, bioMerieux, Cepheid, CytoCore, DiagnoCure, Gen-Probe, Genomic Health, QIAGEN Marseille (Earlier Ipsogen), Myriad Genetics, Panacea Pharmaceuticals, Qiagen, Siemens Heathcare Diagnostics, Roche, Ventana Medical Systems, Trovagene, and Vermillion.

    Key Market Segments

    Type

    Laboratory Tests

    Genetic Tests

    Imaging

    Endoscopy

    Application

    Bladder Cancer Test

    Breast Cancer Test

    Cervical Cancer Test

    Colorectal (Colon) Cancer Test

    Ovarian Cancer Test

    Prostate Cancer Test

    Liver Cancer Test

    Flow Cytometry

    Other Organ Specific Cancer Test

    Key Market Players included in the report:

    Abbott

    Radient Pharmaceuticals

    BD Diagnostics

    Beckman Coulter

    BioCurex

    bioMerieux

    Cepheid

    CytoCore

    DiagnoCure

    Gen-Probe

    Genomic Health

    QIAGEN Marseille (Earlier Ipsogen)

    Myriad Genetics

    Panacea Pharmaceuticals

    Qiagen

    Siemens Heathcare Diagnostics

    Roche

    Ventana Medical Systems

    Trovagene

    Vermillion

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Cancer Test Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Cancer Test Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Cancer Test Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Cancer Test Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Cancer Test Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Cancer Test Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Cancer Test sub-markets, depending on key regions (various vital states).
    To analyze Cancer Test Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Cancer Test Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Cancer Test Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content

    1. Cancer Test Market Introduction

    1.1. Definition
    1.2. Taxonomy
    1.3. Research Scope

    2. Executive Summary

    2.1. Key Findings by Major Segments
    2.2. Top strategies by Major Players

    3. Global Cancer Test Market Overview

    3.1. Cancer Test Market Dynamics

    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges

    3.2. PESTLE Analysis
    3.3. Opportunity Map Analysis
    3.4. PORTER’S Five Forces Analysis
    3.5. Market Competition Scenario Analysis
    3.6. Product Life Cycle Analysis
    3.7. Opportunity Orbits
    3.8. Production Analysis by Region/Company
    3.9. Industry chain Analysis
    3.10. Marketing Strategy

    4. Global Cancer Test Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028

    4.1. Global Cancer Test Market Analysis by Type: Introduction
    4.2. Market Size and Forecast by Region
    4.3. Laboratory Tests

    4.4. Genetic Tests

    4.5. Imaging

    4.6. Endoscopy

    5. Global Cancer Test Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028

    5.1. Global Cancer Test Market Analysis by Application: Introduction
    5.2. Market Size and Forecast by Region
    5.3. Bladder Cancer Test

    5.4. Breast Cancer Test

    5.5. Cervical Cancer Test

    5.6. Colorectal (Colon) Cancer Test

    5.7. Ovarian Cancer Test

    5.8. Prostate Cancer Test

    5.9. Liver Cancer Test

    5.10. Flow Cytometry

    5.11. Other Organ Specific Cancer Test

    6. Global Cancer Test Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028

    6.1. North America

    6.1.1. North America Cancer Test Market: Regional Trend Analysis

    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico

    6.2.1. Europe

    6.2.1. Europe Cancer Test Market: Regional Trend Analysis

    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Spain
    6.2.1.7. Rest of Europe

    6.3. Asia-Pacific

    6.3.1. Asia-Pacific Cancer Test Market: Regional Trend Analysis

    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia-Pacific

    6.4. Latin America

    6.4.1. Latin America Cancer Test Market: Regional Trend Analysis

    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America

    6.5. Middle East and Africa

    6.5.1. Middle East and Africa Cancer Test Market: Regional Trend Analysis

    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA

    7. Global Cancer Test Market Competitive Landscape, Market Share Analysis, and Company Profiles

    7.1. Market Share Analysis
    7.2. Company Profiles
    7.3. Abbott

    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments

    7.4. Radient Pharmaceuticals

    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments

    7.5. BD Diagnostics

    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments

    7.6. Beckman Coulter

    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments

    7.7. BioCurex

    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments

    7.8. bioMerieux

    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments

    7.9. Cepheid

    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments

    7.10. CytoCore

    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments

    7.11. DiagnoCure

    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments

    7.12. Gen-Probe

    7.12.1. Company Overview
    7.12.2. Financial Highlights
    7.12.3. Product Portfolio
    7.12.4. SWOT Analysis
    7.12.5. Key Strategies and Developments

    7.13. Genomic Health

    7.13.1. Company Overview
    7.13.2. Financial Highlights
    7.13.3. Product Portfolio
    7.13.4. SWOT Analysis
    7.13.5. Key Strategies and Developments

    7.14. QIAGEN Marseille (Earlier Ipsogen)

    7.14.1. Company Overview
    7.14.2. Financial Highlights
    7.14.3. Product Portfolio
    7.14.4. SWOT Analysis
    7.14.5. Key Strategies and Developments

    7.15. Myriad Genetics

    7.15.1. Company Overview
    7.15.2. Financial Highlights
    7.15.3. Product Portfolio
    7.15.4. SWOT Analysis
    7.15.5. Key Strategies and Developments

    7.16. Panacea Pharmaceuticals

    7.16.1. Company Overview
    7.16.2. Financial Highlights
    7.16.3. Product Portfolio
    7.16.4. SWOT Analysis
    7.16.5. Key Strategies and Developments

    7.17. Qiagen

    7.17.1. Company Overview
    7.17.2. Financial Highlights
    7.17.3. Product Portfolio
    7.17.4. SWOT Analysis
    7.17.5. Key Strategies and Developments

    7.18. Siemens Heathcare Diagnostics

    7.18.1. Company Overview
    7.18.2. Financial Highlights
    7.18.3. Product Portfolio
    7.18.4. SWOT Analysis
    7.18.5. Key Strategies and Developments

    7.19. Roche

    7.19.1. Company Overview
    7.19.2. Financial Highlights
    7.19.3. Product Portfolio
    7.19.4. SWOT Analysis
    7.19.5. Key Strategies and Developments

    7.20. Ventana Medical Systems

    7.20.1. Company Overview
    7.20.2. Financial Highlights
    7.20.3. Product Portfolio
    7.20.4. SWOT Analysis
    7.20.5. Key Strategies and Developments

    7.21. Trovagene

    7.21.1. Company Overview
    7.21.2. Financial Highlights
    7.21.3. Product Portfolio
    7.21.4. SWOT Analysis
    7.21.5. Key Strategies and Developments

    7.22. Vermillion

    7.22.1. Company Overview
    7.22.2. Financial Highlights
    7.22.3. Product Portfolio
    7.22.4. SWOT Analysis
    7.22.5. Key Strategies and Developments

    8. Assumptions and Acronyms
    9. Research Methodology
    10. Contact

  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. Office No 8, 3rd Floor, Aston Plaza, Katraj - Ambegaon Road, Ambegaon BK, Pune, Maharashtra, India. Pin- 411046